Israeli stem cell collaboration to change insulin need for Diabetes 1 patients

The Australian  Foundation for Diabetes Research has entered into an arrangement with Israeli company Kadimastem to explore overcoming the need for insulin administration in people with type 1 diabetes.

The AFDR has bioengineered a device that when seeded with insulin-producing cells and implanted in diabetic animals normalizes blood glucose levels for up to 3 months.

Kadimastem has developed a way of differentiating human embryonic stem cells into insulin-producing cells that secrete insulin in response to glucose.

Continue here –> JWire.com.au